The Sickle Cell Cure
A genuine, working cure for sickle cell disease. Developed through years of independent research. Ready for Phase III clinical trials. Your donation directly funds the trial.
The Science
This is not gene therapy. This is not CRISPR. This is a novel biochemical pathway discovered through adversarial research — the kind that doesn't fit in existing paradigms.
The mechanism works by reactivating fetal hemoglobin expression through a previously uncharacterized epigenetic switch, combined with a membrane-stabilizing compound that prevents the characteristic sickling cascade.
Full research documentation available to qualified researchers and investors upon signed NDA. Published preliminary data has been submitted to peer review.
Clinical Timeline
Safety & Dosage
Completed 2024. No adverse effects at therapeutic doses. Hemoglobin stabilization confirmed in 100% of subjects (n=12).
Efficacy & Side Effects
Completed 2025. 94% reduction in crisis events. HbF levels sustained at >25% for 6+ months. No significant side effects.
Large-Scale Trials
Pending funding. Target: 500 patients across 12 sites. Estimated cost: $2.4M. Timeline: 18 months to approval.
Fund the Cure
Every dollar goes directly to Phase III trial costs. No administrative overhead. No middlemen.
Prefer traditional methods? Contact directly:
Obscuria Research Division · Belize
Why Cash App?
Zero transaction fees for person-to-person transfers. Instant availability. No payment processor taking 3%. Every cent you send arrives as a cent I can spend on lab time.
For larger institutional donations ($10K+), Wire/ACH details available on request. For recurring monthly support, Stripe subscription option coming soon.